Sphingolipids and insulin resistance: the five Ws
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Inhibition of sphingolipid synthesis increases insulin sensitivity, resolves hepatic steatosis, and prevents the onset of diabetes in obese rodents. I herein review these interventional studies, aiming to summarize the five Ws - the 'Who, What, Where, When, and Why' questions that need to be addressed to understand roles of sphingolipids in the pathogenesis of diabetes. RECENT FINDINGS: Who: ceramides and glucosylceramides are likely to be independent antagonists of insulin action. Where: recent data suggest that ceramides may inhibit insulin action in skeletal muscle, whereas glucosylceramides may be more efficacious in adipose tissue. In contrast, sphingolipid accumulation in the liver appears to be insufficient to induce insulin resistance. What: ceramides and glucosylceramides inhibit different insulin signaling events, but it is unclear whether these actions account for the broad spectrum of therapeutic benefits resulting from sphingolipid depletion. When: recent data suggest that obesity-induced inflammation is important for the induction of sphingolipid synthesis. Why: sphingolipids have an evolutionarily conserved role to starve cells of nutrients, and the inhibition of insulin action is possibly a component of this broader action. SUMMARY: Despite considerable attention to the question of how sphingolipids induce metabolic disease, there exist enormous gaps in knowledge. Further elucidation of these molecular details will be essential for the development of new therapeutic strategies for inhibiting sphingolipid action and ameliorating metabolic diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ceramides have been linked to hepatic IR, and they inhibit several mediators of the insulin signalling pathway, such as insulin receptor substrate 1, phosphatidylinositol 3-kinase, and Akt.118”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [118]
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274
RetractedCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Self-citationThe Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200008200 · Cited by 907
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Self-citationDe Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway
Merrill, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200009200 · Cited by 617
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Self-citationDistinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function
Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552
Cited by
Items 101–135 of 135
Sphingosine Kinase-1/sphingosine 1-phosphate pathway in diabetic nephropathy
Yanhui, D., Lan, T., Juan, H., & Heqing, H. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20133344 · Cited by 16
Ceramide dependent lipotoxicity in metabolic diseases
Li, Y., Tippetts, T. S., & Chaurasia, B. (2017) · Nutrition and Healthy Aging · doi:10.3233/nha-170032 · Cited by 16
Casteras, S., Abdul-Wahed, A., Soty, M., Vulin, F., Guillou, H., Campaña, M. B., Stunff, H. L., Pirola, L., Rajas, F., Mithieux, G., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4097-y · Cited by 14
Finlin, B. S., Varma, V., Nolen, G. T., Dubé, J. J., Starnes, C. P., Rasouli, N., Kern, P. A., & Peterson, C. A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.013 · Cited by 13
Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease
Guo, J., Feng, J., Qu, H., Xu, H., & Zhou, H. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120434 · Cited by 12
Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease
de la Monte, S. M., & Tong, M. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch1 · Cited by 10
Deevska, G. M., Dotson, P. P., Mitov, M. I., Butterfield, D. A., & Nikolova‐Karakashian, M. (2021) · Cells · doi:10.3390/cells10061278 · Cited by 9
Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus
Gueuvoghlanian‐Silva, B. Y., Cordeiro, F. B., Lobo, T. F., Cataldi, T. R., Turco, E. G. L., Bertolla, R. P., Mattar, R., Torloni, M. R., & Daher, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144027 · Cited by 11
Leung, Y. H., Kenéz, Á., Grob, A. J., Feige, K., & Warnken, T. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16200 · Cited by 6
Zimmer, J. K., Takahashi, T., Duess, J. W., Hofmann, A., & Puri, P. S. (2015) · Pediatric Surgery International · doi:10.1007/s00383-015-3825-6 · Cited by 6
Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Ramanadham, S., TURK, J. W., & Bhatnagar, S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220031 · Cited by 13
Metabolomics: a new frontier in neurodegenerative disease biomarker discovery
Verma, K. K., Gaur, P. K., Gupta, S. L., Lata, K., Kaushik, R., & Sharma, V. M. (2025) · Metabolomics · doi:10.1007/s11306-025-02267-7 · Cited by 8
Hassouneh, L. K., Timofiychuk, O. A., & Babenko, N. A. (2018) · General Physiology and Biophysics · doi:10.4149/gpb_2017020 · Cited by 7
Barquissau, V., & Morio, B. (2011) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2011.07.003 · Cited by 10
Patel, R. P., Varghese, J. F., & Yadav, U. C. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_11 · Cited by 5
The role of sphingolipids in heart failure
Hamouche, R., Summers, S. A., Holland, W. L., Navankasattusas, S., Drakos, S. G., & Tseliou, E. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf035 · Cited by 7
Self-citationMarques, C., Blaase, L., & Lanekoff, I. (2024) · Metabolites · doi:10.3390/metabo14110587 · Cited by 6
A Design Space of Behavior Change Interventions for Responsible Data Science
Zhang, D., Barrett, T., Patil, A., Shoda, Y., Battle, L., & Wall, E. (2025) · ACM International Conference on Intelligent User Interfaces (IUI) · doi:10.1145/3708359.3712140 · Cited by 6
Metabolomic signatures of cognitive function in a type 2 Diabetes-Enriched cohort
Powell, J., Hugenschmidt, C. E., Hsu, F., Flashman, L. A., Xu, J., Bowden, D. W., Freedman, B. I., & Palmer, N. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-99606-4 · Cited by 2
Norris, M. K., Tippetts, T. S., Wilkerson, J. L., Nicholson, R. J., Maschek, J. A., Levade, T., Medin, J. A., Summers, S. A., & Holland, W. L. (2024) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2024.101077 · Cited by 2
Self-citationP2‐048: Plasma sphingomyelin is associated with cognitive progression in Alzheimer's Disease
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.937 · Cited by 2
Taiwo, A., Thakkar, H., Maschek, J. A., Cox, J. E., Summers, S. A., Jalal, D. I., Dokun, A. O., Sivitz, W. I., & Chaurasia, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-15778-z · Cited by 2
Self-citationMuscle Biopsy to Investigate Mitochondrial Turnover
Barazzoni, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-27192-2_7 · Cited by 1
Muscle Biopsy To Investigate Mitochondrial Turnover
Barazzoni, R. (2012) · Springer eBooks · doi:10.1007/978-88-470-2418-2_8 · Cited by 1
Obesity and related metabolic diseases – role of chronic inflammation
Guha, S., & Majumder, K. (2020) · Diabesity · doi:10.15562/diabesity.2020.68 · Cited by 1
Orm2 protein level regulates sphingolipid synthesis in response to environmental stress in yeast
Federman, R. S. (2013) · Deep Blue (University of Michigan) · Cited by 1
Martins, A. R. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2014.tde-05012015-152951
Xavier, D. J. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2013.tde-29082013-154529
Cellular Lipids and Inflammation
Heber, D., & Henning, S. M. (2014) · CRC Press eBooks · doi:10.1201/b16661-4
Manzanares‐Estreder, S. (2017) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/79083
Saleem, M. (2017) · TSpace (University of Toronto)
Kong, L., Shi, J., Wang, S., Huang, J., Ge, Y., Li, Z., Li, K., Zhao, M., Li, Z., & Jin, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07989-3 · Cited by 2
Homéostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63 · Cited by 1
Jamil, M., Kovilakath, A., Valentine, Y. A., Farooq, S., Montefusco, D. J., Yue, Y., Beutner, G., Chen, Q., Thompson, J., Myakala, K., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113630
Metadata
- Authors
- Summers, S. A.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Summers, Scott A
- ORCID
- Summers, Scott A
- Venue
- Current Opinion in Lipidology
- Published
- 2010-04
- Volume
- 21
- Issue
- 2
- Pages
- 128-135
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2023794522
- Cited by
- 136
- References
- 73
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 11 · 2016: 7 · 2015: 9 · 2014: 11 · 2013: 9 · 2012: 22
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK081456, R01DK081456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- sphingolipids, insulin resistance, ceramide, glucosylceramide, hepatic steatosis, obesity, diabetes mellitus, skeletal muscle insulin signaling, adipose tissue, obesity-associated inflammation, metabolic disorders, nutrient deprivation
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Obesity, Sphingolipids, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.